HOME
PRODUCTS
TRIAGE SYSTEM
CARDIAC PANEL
Chest Pain & ACS
Cardiac Markers
Clinical Significance
Economics & Diagnosis
Guidelines
Product Info
Publications & Abstracts
Case Studies
Rapid MI Rule-Out
Rapid MI Rule-In
Ordering Info
Request Info
Customer Service
FAQs
Resources
BNP TEST
PROFILER SHORTNESS OF BREATH PANEL
D-DIMER TEST
TOX DRUG SCREEN
DRUGS OF ABUSE PANEL
C. difficile PANEL
PARASITE PANEL
REIMBURSEMENT
Biosite Inc.

Triage® Cardiac Panel: Value of Three Marker Panel

Cardiac markers are characterized by cardiospecificity and sensitivity. Attributes of an “ideal” marker include the following:

  • Cardio-sensitive–Found in high concentration in the heart
  • Cardio-specific–Not found in other tissues, even in trace amounts or under pathological conditions
  • Low molecular weight and thus released in early course of acute myocardial infarction

Currently, no marker by itself fulfills the attributes of an ideal marker. However, current studies support a panel of markers approach. Myoglobin, CK-MB and troponin I, when used simultaneously, meet the attributes of an ideal marker for the diagnosis of acute myocardial infarction.

Three recent studies support the use of cardiac markers in combination as a panel approach to diagnose acute myocardial infarction. Additionally, two of the studies independently found a 90-minute decision point to be valuable in determining further testing or treatment. Unfortunately, most current hospital protocols for serial testing begin six to eight hours following the emergency department presentation, thereby precluding effective treatment.

Biosite’s Clinical Consultants can customize multimarker strategies to fit your hospital’s protocols for diagnosing chest pain patients. Please call Technical Service at 1-888-246-7483 ext. 12 for more information.